Portfolio Review: Biogen & T. Rowe Price

Biogen reported second quarter sales declined 25% to $2.8 billion. T. Rowe Price reported strong second quarter results with revenues rising 36% to $1.9 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.